Get started
Jaguar Health, Inc.Jaguar Health, Inc.Jaguar Health, Inc.

Jaguar Health, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

JAGX trade ideas

$JAGX 30yr SHORT story, might actually Flip on Ph3 DATAI honestly think it's the Shaman Pharmaceuticals equity investors, and the last 28 years or so of people who lost all their money from the early 90s to now. This is a 30 year story. Lisa the ceo began this journey in 1989. So many peoples money. So so so many. But now that the ph3 data is literally about to come out on several new indications for the drug and all the bashing? Fake articles? Why would someone take the time out of their day to be so negative on something if they didn't want it THEMSELVES. #BTD
NASDAQ:JAGXLong
by CryptoArmory
4
JAXG, a lowkey health stock with multi bagger growth prospect!After skimming on low cap stocks which have huge growth potential but have been on signficant correction, I came across JAGX, a pharmaceutical company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines. Weekly data is showing weakening of sellers. An accumulation / net buying at the current price range has been spotted. Volume have increased from 1.73M to 2.22M. Again, its a low cap -- and the catch with low cap stocks is liquidity. Be mindful on that aspect. Spotted at 0.6090 TAYOR.
NASDAQ:JAGXLong
by JSAL
JAGX | Close to a Bottom? | BounceJaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
NASDAQ:JAGXLong
by DivergenceSeeker
5
#JAGX Price breaking wedge at apex level with huge volumes!🔥GO!Hi All, my main 3 take-outs from this analysis are the following: 1- Price brke the descending wedge at apical level with huge volumes. The movement was quite predictable as the prices were compressing more and more at the apex 2- My long term targets stays at around 6$-7$, as result of the wedge height projection and the breakout point 3- RSI indicating momentum approaching 50 level and pointing upward. Retracements are possible, but in the long term I am strongly bullish on Jaguar Not a financial advice, just personal opinion. Do your own due diligence and good luck!
NASDAQ:JAGXLong
by FrancescoMerlettini
JAGX Detailed Video AnalysisThis video analysis is for DebonairLizard who requested this for all you guys to benefit from. i show you a potential buy zone and targets that may be taking this asset higher. lets see if it plays out as we patiently wait for this asset's price to come down to more reasonable buy areas. thank you for your valuable time. Also for all you amazing people who are offering donations please send those to my home church at CALVARYPSL.COM they need your assistance to reach people globally. Rigo
NASDAQ:JAGXLong
by rigorocks
38
jagx finally approaching the buy zonei hope you guys are all doing well. so after about a year of waiting and what looks to be a reverse stock split that altered the chart slightly it looks like we about to approach the landing zone. the landing zone is the 89% and 95% fibonacci retracement levels. a potential 1000% trade setup. there is also a nice big gap that has yet to be filled on the daily time frame that lines up with the 95% area. the target is north of $20. we have seen targets like this play out in other stocks so this one shouldn't surprise anyone especially if it breaks the down trending line in a big way good luck and happy trading everyone Rigo
NASDAQ:JAGXLong
by rigorocks
1
My View on JAGXThis is the short-term play. JAGX is a nice breakout after 4 touches the trendline and trading at $1.75. My prediction in the short term is that JAGX would reach $2.65 next week (around 50% gain), set STOP LOSS below $1.58 (around 10% loss). Trading with a small amount (less than $5000). ----------------------------------------------------------------------- This is not financial advice. I'm not a Financial Advisor. Trading is a high risk, do your own DD. Let me know what you think Cheers, I would share all my thought next time. PEACE.
NASDAQ:JAGXLong
by TheBullishMan
20